Analysis of human mesenchymal stem cells on a cross-linked collagen-based surgical implant material

Turkan Arca, Joanne Proffitt, Paul Genever*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Biomimetic scaffolds, delivered to the patient with or without cell loading, can offer improved treatments for a range of damaged or diseased tissues. In this work we evaluated the capacity of a cross-linked collagen-based implant material (Permacol (TM)) to support the survival and growth of multipotent stromal cells or mesenchymal stem cells (MSCs) for potential applications in soft-tissue reconstruction and compared it to uncross-linked collagen. We showed, using confocal imaging, histology, quantitative analysis of seeding efficiencies by the MTT assay and Live/Dead analysis, that Permacol (TM) supported the adherence, growth and survival of MSCs preserving a healthy cell phenotype. MSCs infiltrated both matrices, although migration rates were significantly higher on uncross-linked matrices for some donors. Our work demonstrates that Permacol (TM) could maintain human MSCs in long-term culture supporting its use as a cell-seeded biomaterial for durable and strong repair in tissue reconstruction.

Original languageEnglish
Pages (from-to)261-276
JournalBio-Medical materials and engineering
Volume22
Issue number5
Early online date28 Sept 2012
DOIs
Publication statusPublished - 2012

Keywords

  • Mesenchymal human stem cells
  • collagen implant material
  • regenerative
  • surgical
  • PORCINE DERMAL COLLAGEN
  • SOFT-TISSUE RECONSTRUCTION
  • ADIPOSE-DERIVED STEM
  • HERNIA REPAIR
  • RAT MODEL
  • IN-VITRO
  • MATRIX
  • LINKING
  • PERMACOL(TM)
  • SCAFFOLDS

Cite this